Tempest Therapeutics, Inc.
TPST
$6.87
$0.385.86%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -41.84M | -35.52M | -31.75M | -29.76M | -29.49M |
| Total Depreciation and Amortization | 389.00K | 425.00K | 416.00K | 344.00K | 381.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.81M | 6.75M | 6.14M | 5.30M | 4.43M |
| Change in Net Operating Assets | 1.61M | -705.00K | -163.00K | -2.13M | -2.68M |
| Cash from Operations | -33.03M | -29.05M | -25.36M | -26.24M | -27.36M |
| Capital Expenditure | -435.00K | -439.00K | -424.00K | -292.00K | -170.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -435.00K | -439.00K | -424.00K | -292.00K | -170.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -4.40M | -2.20M | -- | -- | -- |
| Issuance of Common Stock | 28.90M | 43.10M | 39.38M | 36.01M | 35.60M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 24.50M | 40.90M | 39.38M | 36.01M | 35.60M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -8.96M | 11.41M | 13.60M | 9.48M | 8.08M |